Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium-Reference-Cited by-同舟云学术

Directed Differentiation of Human Induced Pluripotent Stem Cells into Fallopian Tube Epithelium

Published:2017-09-06 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Yucer Nur,Holzapfel Marie,Jenkins Vogel Tilley,Lenaeus Lindsay,Ornelas Loren,Laury Anna,Sareen Dhruv^ORCID,Barrett Robert,Karlan Beth Y.,Svendsen Clive N.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-05519-2.pdf

Reference36 articles.

1. Kurman, R. J. Origin and molecular pathogenesis of ovarian high-grade serous carcinoma. Ann Oncol 24(Suppl 10), x16–21, doi: 10.1093/annonc/mdt463 (2013).

2. Jones, P. M. & Drapkin, R. Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms. Front Oncol 3, 217, doi: 10.3389/fonc.2013.00217 (2013).

3. Levanon, K., Crum, C. & Drapkin, R. New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol 26, 5284–5293, doi: 10.1200/JCO.2008.18.1107 (2008).

4. Folkins, A. K. et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol 109, 168–173, doi: 10.1016/j.ygyno.2008.01.012 (2008).

5. Leonhardt, K., Einenkel, J., Sohr, S., Engeland, K. & Horn, L. C. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary. Int J Gynecol Pathol 30, 417–424, doi: 10.1097/PGP.0b013e318216d447 (2011).

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The reprotoxic adverse side effects of neurogenic and neuroprotective drugs: current use of human organoid modeling as a potential alternative to preclinical models;Frontiers in Pharmacology;2024-06-14

2. Optimizing Nodal, Wnt and BMP signaling pathways for robust and efficient differentiation of human induced pluripotent stem cells to intermediate mesoderm cells;Frontiers in Cell and Developmental Biology;2024-06-03

3. Improving the Lives of Women With Ovarian Cancer;Clinical Obstetrics & Gynecology;2024-01-15

4. Current and future perspectives of xenograft models of human ovarian cancer;Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks;2024

5. Multifaceted Role of Induced Pluripotent Stem Cells in Preclinical Cardiac Regeneration Research;Handbook of Stem Cell Applications;2024